136 related articles for article (PubMed ID: 38156404)
1. Roxadustat ameliorates vascular calcification in CKD rats by regulating HIF-2α/HIF-1α.
Wang Y; Xiao M; Cai F; Li Y; Shi T; Zhou X; Tian S; Huang D
Environ Toxicol; 2024 Apr; 39(4):2363-2373. PubMed ID: 38156404
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification.
Mokas S; Larivière R; Lamalice L; Gobeil S; Cornfield DN; Agharazii M; Richard DE
Kidney Int; 2016 Sep; 90(3):598-609. PubMed ID: 27470678
[TBL] [Abstract][Full Text] [Related]
3. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease leads to hypoxia inducible factor-1alpha to hypoxia inducible factor-2alpha switch in the gastrocnemius muscle.
Flisinski M; Wisniewska-Chudy E; Brymora A; Stefanska A; Strozecki P; Manitius J
J Physiol Pharmacol; 2017 Jun; 68(3):419-425. PubMed ID: 28820398
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease.
Csiki DM; Ababneh H; Tóth A; Lente G; Szöőr Á; Tóth A; Fillér C; Juhász T; Nagy B; Balogh E; Jeney V
Front Cardiovasc Med; 2023; 10():1168339. PubMed ID: 37332579
[TBL] [Abstract][Full Text] [Related]
6. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.
Ahmad A; Ahmad S; Malcolm KC; Miller SM; Hendry-Hofer T; Schaack JB; White CW
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):78-85. PubMed ID: 23492195
[TBL] [Abstract][Full Text] [Related]
8. Role of prolyl hydroxylase/HIF-1 signaling in vascular calcification.
Negri AL
Clin Kidney J; 2023 Feb; 16(2):205-209. PubMed ID: 36755843
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells.
Caprara V; Scappa S; Garrafa E; Di Castro V; Rosanò L; Bagnato A; Spinella F
Life Sci; 2014 Nov; 118(2):185-90. PubMed ID: 24607784
[TBL] [Abstract][Full Text] [Related]
10. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
[TBL] [Abstract][Full Text] [Related]
11. Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathway.
Li L; Li A; Zhu L; Gan L; Zuo L
J Orthop Surg Res; 2022 May; 17(1):286. PubMed ID: 35597989
[TBL] [Abstract][Full Text] [Related]
12. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a.
Caus M; Alonso-Montes C; Fernandez-Martin JL; Marti-Antonio M; Bozic M; Valdivielso JM
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1533-1548. PubMed ID: 37381989
[TBL] [Abstract][Full Text] [Related]
14. PRMT3 methylates HIF-1α to enhance the vascular calcification induced by chronic kidney disease.
Zhou G; Zhang C; Peng H; Su X; Huang Q; Zhao Z; Zhao G
Mol Med; 2024 Jan; 30(1):8. PubMed ID: 38200452
[TBL] [Abstract][Full Text] [Related]
15. Differential expressions and roles of hypoxia-inducible factor-1alpha, -2alpha and -3alpha in the rat carotid body during chronic and intermittent hypoxia.
Lam SY; Tipoe GL; Liong EC; Fung ML
Histol Histopathol; 2008 Mar; 23(3):271-80. PubMed ID: 18072084
[TBL] [Abstract][Full Text] [Related]
16. Mutual Antagonism of Hypoxia-Inducible Factor Isoforms in Cardiac, Vascular, and Renal Disorders.
Packer M
JACC Basic Transl Sci; 2020 Sep; 5(9):961-968. PubMed ID: 33015417
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α/PDK4/autophagy pathway protects against advanced glycation end-products induced vascular smooth muscle cell calcification.
Yang R; Zhu Y; Wang Y; Ma W; Han X; Wang X; Liu N
Biochem Biophys Res Commun; 2019 Sep; 517(3):470-476. PubMed ID: 31376939
[TBL] [Abstract][Full Text] [Related]
18. Roxadustat Attenuates the Disruption of Epithelial Tight Junction in Caco2 Cells and a Rat Model of CKD Through MicroRNA-223.
Qu N; Chen L; Liang S; Wei M; Sun L; He Q; Xue J; Wang M; Shi K; Jiang H; Liu H
Front Med (Lausanne); 2022; 9():850966. PubMed ID: 35492370
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
[TBL] [Abstract][Full Text] [Related]
20. Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.
Chen A; Lan Z; Li L; Xie L; Liu X; Yang X; Wang S; Liang Q; Dong Q; Feng L; Li Y; Ye Y; Fu M; Lu L; Yan J
Cardiovasc Res; 2023 Oct; 119(13):2368-2381. PubMed ID: 37523743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
